# Celanese Corporation (CE) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $44.67, market value $4.9 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Celanese Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.29**. A PEG of 0.29 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.2×**. The shares trade at 1.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 132.8×**. Enterprise value is 132.8× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 14.4%** (5-yr avg 10.4%). Free cash flow equals 14.4% of the market value, above its five-year average of 10.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 20.9%**. Celanese Corporation keeps 20.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -7.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -12.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -28.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -3.1%**. Return on all capital, debt included, is -3.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.4%**. Each dollar of assets produces -5.4% of profit.

## Growth
- **Revenue growth (1 yr): -7.1%** (3-yr -0.4%/yr, 5-yr 11.0%/yr). Revenue fell 7.1% over the last year, against 11.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 24.6%**. Earnings per share rose 24.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -14.3%/yr**. Free cash flow has compounded at -14.3% a year over three years.

## Financial health
- **Debt to equity: 3.41**. Debt is 3.41 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Current ratio: 1.55** (quick 1.55). Current assets cover the next year's liabilities 1.55 times.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.27%** ($0.12 per share, trailing). Celanese Corporation yields 0.27%, a modest yield more typical of a growth-oriented payer.
- **Dividend growth (5 yr): -45.4%/yr** (1-yr -95.7%). The dividend has not grown over five years.

## Price and momentum
- **Total return (1 yr): -3.6%** (YTD 5.8%, 3-mo -12.4%). The shares are down 3.6% over twelve months including dividends.
- **From 52-week high: -36.8%** (27.2% above the low). Trading 37% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.64** (volatility 54%). Beta of 0.64 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CE · Page: https://foliofundamentals.com/stocks/ce

Not investment advice.